Loading…
Choosing between in-house and outsourced IVD reagent manufacturing is not a one-time make-or-buy calculation. You are choosing where process knowledge lives, who absorbs demand volatility, how quickl…
Choosing a urinalysis platform is not simply a choice between two analyzers. You are deciding how urine chemistry, microscopy, reflex rules, manual review, quality control, data transfer, service, an…
When bioprocess orders rise while customer projects move, you can receive two apparently contradictory signals: demand is strengthening, yet near-term shipments or supplier revenue do not move in ste…
Adding capillary sampling to an established core laboratory can look deceptively simple: keep the analyzer, change the collection device, and begin testing smaller specimens. In practice, you are add…
When you buy a chromatography column for a biotherapeutic workflow, you are not buying a generic tube filled with stationary phase. You are choosing how your method will separate aggregates, recover…
Learn how to assess assay compatibility, platform dependencies, consumables, regulatory limits, and sourcing risks before committing to a diagnostic workflow.
Learn why laboratories are moving beyond individual assay selection and evaluating platform compatibility, automation, workflow efficiency, and sourcing strategies when purchasing molecular diagnosti…
Multiomics research allows you to examine genomic, transcriptomic, proteomic, and other biological information within a connected study. However, combining these methods also makes laboratory procure…
